Sourcing Guide

Buy Tesamorelin

Research-grade Tesamorelin with purity documentation for physiological GHRH receptor activation studies

>=98% purity by HPLCLyophilized powder, 5mg vialsUSA Domestic

Research Context

Tesamorelin is FDA-approved as Egrifta for HIV lipodystrophy, providing one of the most clinically validated GHRH analog research contexts. Phase 3 data from Falutz et al. (NEJM, 2010) documents visceral fat reduction through physiological GH pulse stimulation.

Full Tesamorelin Research Reference →

Tesamorelin Research Supply

>=98% purity by HPLC with batch-specific CoA. Lyophilized powder, 5mg vials.

View Product PageRead Research Reference

Sourcing Guide

What Researchers Look For

Tesamorelin is a complex 44-amino acid peptide with a trans-3-hexenoic acid N-terminal modification, and researchers should specifically verify that the N-terminal modification is present in the supplied compound via mass spectrometry. The expected molecular weight is approximately 5136 Da for the fully modified compound. Preparations lacking the trans-3-hexenoic acid modification would have different pharmacokinetics and potentially different GHRH receptor binding characteristics compared to the FDA-approved Egrifta reference compound.

Why Spartan Peptides

Spartan Peptides supplies Tesamorelin as the fully modified GHRH analog matching the Egrifta pharmaceutical reference at a minimum 98% HPLC purity with batch-specific certificate of analysis. The 5mg vial format aligns with standard research dose quantities. US domestic dispatch ensures rapid delivery for metabolic and GH axis research programs.

Specifications

Purity Standard>=98% purity by HPLC
FormatLyophilized powder, 5mg vials
StorageStore lyophilized at -20 degrees C. Reconstituted, stable 30 days at 4 degrees C.
OriginUSA domestic supply
DocumentationBatch-specific certificate of analysis

Sourcing FAQ

Order Research-Grade Tesamorelin

>=98% purity by HPLC. Lyophilized powder, 5mg vials. Batch-specific CoA. Domestic US supply with same-day dispatch before 2 PM EST.

All compounds are strictly for in-vitro research use only and not intended for human consumption.